| Symbol: |
SERTAD2
|
| Description: |
null
|
| Location: |
null
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:333
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| SERTAD2 |
6,7-dimethyl-1,4-di-N-oxide-3-methylquinoxalin-2-yl-4-(4-nit rophenyl)piperazinyl ketone |
0.002 |
Down |
| SERTAD2 |
NSC 721536 |
0.014 |
Up |
| SERTAD2 |
2-fluorphenylhydrazone alpha-lapachone |
0.008 |
Down |
| SERTAD2 |
4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide |
0.042 |
Up |
| SERTAD2 |
NSC 722876 |
0.001 |
Up |
| SERTAD2 |
NSC 722985 |
0.008 |
Up |
| SERTAD2 |
NSC 723548 |
0.011 |
Up |
| SERTAD2 |
Pyridone-OCH3 |
0.003 |
Down |
| SERTAD2 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.006 |
Down |
| SERTAD2 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.039 |
Up |
| SERTAD2 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.04 |
Up |
| SERTAD2 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.029 |
Up |
| SERTAD2 |
Dasatinib |
0.001 |
Down |
| SERTAD2 |
NSC 732719 |
0.017 |
Up |
| SERTAD2 |
NSC 733155 |
0.009 |
Up |
Expression pattern: Sensitivity / Resistance
Total:23 Current:20
First Prev Next Last
|
| SNP:
~ Export ~
|
Records:null
| SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|